ArticleBiogerontology2026
An integrated resource for systems-level analysis of aging hallmarks and associated genes.
Article in Biogerontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
AgingHallmarksDB is an interactive web platform designed to facilitate systems-level aging research centered on 11 aging hallmarks. It comprises 3111 aging hallmark-associated genes integrated from seven established databases, including a high-confidence consensus set comprising 1089 genes. It further incorporates tissue, cell-type class, exosomes, protein-protein and regulatory interactions to facilitate deeper biological insights. AgingHallmarksDB enables over representation analysis (ORA) and gene set enrichment analysis (GSEA) to elucidate varying molecular mechanisms underlying aging. Gene overlaps and Jaccard similarity revealed interconnectedness among the hallmarks. Network analyses further showed these pairs are connected within the protein-protein interaction (PPI) network. The utility of this resource was demonstrated through multiple hallmark-associated analyses. PPI network topology analysis of common hallmark genes revealed several key age-associated genes that act as central hubs across multiple aging hallmarks. Hallmark enrichment analyses revealed extensive coverage across aging-related diseases compared to limited enrichment seen in non-aging-related diseases like developmental and congenital diseases. Further these analyses showed biologically meaningful disease-associated processes, like "Loss of proteostasis" in Alzheimer's disease and "Chronic inflammation" in atherosclerosis as highly significant hallmarks. These disease-hallmark associations were further supported by network proximity analyses. In addition, GSEA of the PM2.5 exposure-associated skin transcriptome identified significant enrichment of aging hallmarks, particularly "Epigenetic alterations", demonstrating the resource's utility in interpreting transcriptomic datasets within the context of aging biology. Overall, AgingHallmarksDB provides a robust framework for investigating hallmark-associated functionality, and potential therapeutic discovery in aging and longevity. AgingHallmarksDB is accessible at https://cb.imsc.res.in/aginghallmarksdb/ .
Indexed as
Identifiers
42842105What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.